Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesMilnacipran, a serotonin and norepinephrine reuptake inhibitor: a novel treatment for fibromyalgia
International Journal of Clinical Rheumatology, 10/19/09
Leo RJ – Milnacipran hydrochloride is a serotonin (5–HT) and norepinephrine (NE) reuptake inhibitor that was recently approved by the US FDA for the treatment of fibromyalgia (FM). Evidence has accumulated suggesting that, in animal models, milnacipran may exert pain–mitigating influences involving norepinephrine– and serotonin–related processes at supraspinal, spinal and peripheral levels in pain transmission. Milnacipran has demonstrated efficacy for the reduction of pain as well as improvements in global assessments of well–being and functional capacity among treated FM patients. Milnacipran may be of special interest for use in patients for whom hepatic dysfunction precludes the use of other agents, for example, duloxetine. It has a negligible influence on cytochrome metabolism, and therefore may be of particular benefit in patients requiring multiple concurrently prescribed medications.
Related Articles
Developments in the scientific and clinical understanding of fibromyalgia
Arthritis Research & Therapy, 10/16/09
Relevance Score: 65%
Fibromyalgia: The diagnosis and pharmacologic treatment
European Journal of Pain, 11/12/09
Relevance Score: 64%
Changes in Hippocampal Metabolites After Effective Treatment for Fibromyalgia: A Case Study
The Clinical Journal of Pain, 10/20/09
Relevance Score: 47%
Womens narratives on experiences of work ability and functioning in fibromyalgia
Musculoskeletal Care, 10/23/09
Relevance Score: 46%
General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study
BMC Public Health, 11/04/09
Relevance Score: 45%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease
Evidence-Based Medicine, 12/08/09
Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review
Headache: The Journal of Head and Face Pain, 12/08/09
Effects of perioperative intravenous low dose of ketamine on postoperative analgesia in children
European Journal of Anaesthesiology, 12/08/09
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clues on the MDHAQ to Identify Patients with Fibromyalgia and Similar Chronic Pain Conditions
Rheumatic Disease Clinics of North America, 12/08/09
Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study
QJM: An International Journal of Medicine, 12/08/09
Physical Performance as a Predictor of Attention and Processing Speed in Fibromyalgia
Archives of Physical Medicine and Rehabilitation, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor